OTLK

Outlook Therapeutics, Inc. SEC filings

Every EDGAR filing for Outlook Therapeutics, Inc. (OTLK), newest first, with AI summaries and stories.

Ticker
OTLK
CIK
1649989
Sector
Biotech and pharma
Latest filing
5d

Next: 10-K expected ~Dec 23 (deadline Dec 29) · earnings expected ~Dec 28 · usually files the same day as earnings

Watch in the app Get the app

Get an email when Outlook Therapeutics, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  4. ROUTINE4Outlook Therapeutics, Inc.OTLK

    2 insider filings

    Kevin Michael Lundquist, insider filing for OTLK

    Show all 2
    • 4Insider filing for OTLK
    • 3New insider at OTLK

    Kevin Michael Lundquist, reporting

  11. ROUTINE4Outlook Therapeutics, Inc.OTLK

    2 insider filings

    Ghiath M. Sukhtian, insider filing for OTLK

    Show all 2
    • 4Insider filing for OTLK
    • 4Insider filing for OTLK

    Ghiath M. Sukhtian, reporting · GMS Ventures & Investments, reporting

  20. ROUTINE4Outlook Therapeutics, Inc.OTLK

    2 insider filings

    Lawrence A Kenyon, insider filing for OTLK

    Show all 2
    • 4Insider filing for OTLK
    • 4Insider filing for OTLK

    Lawrence A Kenyon, reporting

  37. ROUTINE4Outlook Therapeutics, Inc.OTLK

    4 insider filings

    Faisal Ghiath Sukhtian, insider filing for OTLK

    Show all 4
    • 4Insider filing for OTLK
    • 4Insider filing for OTLK
    • 4Insider filing for OTLK
    • 4Insider filing for OTLK

    Faisal Ghiath Sukhtian, reporting

Older filings on EDGAR